May 2005

Contents

Editorial

• Volume 6 Number 5 May 2005

Conference reports

• 3rd European HIV Drug Resistance Workshop, 30 March-1 April 2005, Athens

• Tenofovir, nucleosides, and non-nucleosides

• Protease inhibitors

• CCR5 antagonists

• Paediatric reports from 12th Conference on Retrovirus and Opportunistic Infections (CROI)

• Once-daily lopinavir/ritonavir for children may offer advantages

• Lopinavir/ritonavir for young infants

• Paediatric dose finding atazanavir and atazanavir/ritonavir

• Switching d4T to tenofovir and protease inhibitor to efavirenz

Treatment access

• Millions in Global Fund grants go unused: Indian government bureaucracies kill off people living with AIDS

Paediatric care

• US guidelines on paediatric care updated (March 2005)

Guidelines

• Draft BHIVA treatment guidelines online for comment

• UK guidelines for liver transplant in HIV-positive patients

OIs, coinfections and complications

• Lymphogranuloma venereum – an overview: update on UK cases of LGV

Hepatitis coinfection

• Sexual HCV reinfection of HIV-positive gay man while receiving PEG-interferon plus ribavirin

• First European recommendations for the treatment of patients co-infected with HIV and HBV/HCV

Other news

• Newly acquired HIV infections are key to transmission

• Calls to i-Base phoneline now free from Orange mobile networks

• Request for overseas volunteers

On the web

• 40th European Association for the Study of the Liver (EASL)

• Community impact of New York case of HIV infection with multidrug-resistant dual-tropic HIV-1 and rapid progression to AIDS

• Integration of buprenorphine into primary HIV care

• HIV inSite Knowledge Base

PDFs

• Volume 6 Number 5 May 2005 PDF